Dr. Gil I. Wolfe, MD

Dr. Wolfe practices at University Neurology, Inc. in Buffalo, New York.

Dr. Wolfe's NPI, 1215995535, was assigned on May 3, 2006. Dr. Wolfe graduated from University of Texas Southwestern Medical School in 1989. Dr. Wolfe holds New York license 264033.

Dr. Wolfe's primary practice is University Neurology, Inc., at 1001 Main St, Buffalo, NY 14203 in Erie County. The practice phone is (716) 878-2497.

Dr. Wolfe's primary practice is University Neurology, Inc. in Buffalo, New York. Dr. Wolfe is also affiliated with Buffalo General Medical Center/Gates Vascular Institute. The medical group on file is Kaleida Health. Dmand AI also links Dr. Wolfe to 4 more hospitals, 6 medical groups and 4 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wolfe practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Wolfe's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Wolfe's licenses on file in 2 states: New York and Texas.

CMS data shows 837 Medicare services from Dr. Wolfe across 6 procedure codes in 2024, for 118 Medicare patients. Medicare paid $24,239 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 118 Medicare patients who saw Dr. Wolfe in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wolfe's median patient age at 69, with 48% women.

In 2024, Dr. Wolfe wrote 225 Medicare Part D claims for 37 patients. 92% of them were for generic drugs. CMS names the drug for 141 of them, across 4 drugs with 11 or more claims each, at $5,716 in total drug cost. In 2023, CMS named 151 claims across 6 drugs.

Dr. Wolfe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 62 papers to Dr. Wolfe, published from 2011 to 2025. 2024 was the busiest year, with 7. The most frequent topics are Myasthenia Gravis, Thymectomy and Receptors, Cholinergic. Dr. Wolfe has published most often in Muscle Nerve. Dr. Wolfe's most frequent co-authors are Nicholas J. Silvestri, MD, Donald Berry Sanders, MD and Michael Benatar, MD.

Dmand AI links Dr. Wolfe to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Myasthenia Gravis, Neuromuscular Junction Diseases and Agnosia. Open Payments lists research payments to Dr. Wolfe that name 1 trial.

CMS Open Payments shows 906 general payments to Dr. Wolfe from 30 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 42% of the total. Alexion Pharmaceuticals, Inc. paid the most, $246,862. It also lists 7 research payments totaling $3,979 from 2021 to 2025, naming 1 clinical trial.

Dr. Wolfe graduated from University of Texas Southwestern Medical School in 1989.